Andy Eckert

Andy Eckert most recently served as Chief Executive Officer of Zelis, a healthcare payments and cost containment business. Prior to Zelis, Andy was CEO of KCI from 2017 until its sale to 3M in 2019. Prior to this, he was Chief Executive Officer of Valence Health, an emerging leader in value-based healthcare, Chief Executive Officer of TriZetto, a leader in payer information technology, and both Chairman and Chief Executive Officer of CRC Health Group, the leading behavioral health treatment provider owned by Bain Capital. Andy began his career at ADAC Laboratories, spending four years as Chairman and Chief Executive Officer until its sale to Philips Medical systems in 2000. Andy has served on a number of corporate boards and is currently the Chairman of Kipu Health, as well as a Director at Becton, Dickinson and Company. He earned a B.S. in from Stanford University in Industrial Engineering and an M.B.A. from Stanford University.